Skip to content

menu

Rothwell, Figg, Ernst & Manbeck, P.C. logo
Current Page:HomeAboutContact
RF EMerge logo

A Resource for Innovators

Topics

GuidanceTrends & AnalysisLegal DevelopmentsSubscribe

Featured

A bag with ideas or patents and a shield. The concept of protection of copyright and patents for inventions. Non-disclosure agreement. trade secrets and industrial espionage. Technology Abduction

Considerations for Protecting your Invention with Provisional Patent Applications

By Xiaoban Xin on February 26, 2021

Since the U.S. patent law switched to the first-inventor-to-file system in 2013, provisional applications have…

Continue Reading Considerations for Protecting your Invention with Provisional Patent Applications

Dana-Farber Launches New Fund to Support Oncology Startups

By Dan Shores on January 29, 2021

2021 started off well for Dana-Farber Cancer Institute, with the launch of its new…

Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups
Human Crowd Forming Registered Trademark Symbol on White Background : Patent and Copyright Concept

Practice Tips: Fair Use of a Trademark (Part II)

By Davide F. Schiavetti on January 21, 2021

Sometimes it is necessary to use a third-party trademark to refer to the owner of…

Continue Reading Practice Tips: Fair Use of a Trademark (Part II)
Latest
Aerial view of crowd connected by lines

Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research

By Xiaoban Xin on January 26, 2021
Posted in Trends & Analysis

On January 11, 2020, the Broad Institute, Verily Life Sciences, and Microsoft announced a strategic partnership to accelerate biomedical innovations…
Continue Reading Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research

Incentive Stock Photo

USPTO Incentive Policies Influence Patentability Decisions

By Eric D. Blatt on January 19, 2021
Posted in Guidance

U.S. Patent and Trademark Office human resource policies influence patentability decisions, potentially increasing the rate at which examiners issue allowances.…
Continue Reading USPTO Incentive Policies Influence Patentability Decisions

Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development

By Caitlin Wilmot on January 8, 2021
Posted in Featured, Trends & Analysis

Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye…
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development

The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeuticsnetwork concept. Human resources. Teamwork of business. Partnership.

The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics

By Anjali Jenna (AJ) Teigen on January 7, 2021
Posted in Featured, Trends & Analysis

The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company…
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics

Patent And Trademark Office Headquarters

How to Reduce Fees and Speed Time to Allowance at the US Patent & Trademark Office

By Dylan Haversack on December 22, 2020
Posted in Guidance

It is advantageous for emerging companies to highlight their patent portfolio when seeking to attract investment, forge strategic partnerships, enter…
Continue Reading How to Reduce Fees and Speed Time to Allowance at the US Patent & Trademark Office

Cadent Therapeutics Acquired by Novartis for Up to $770 Million

By Aydin H. Harston on December 18, 2020
Posted in Trends & Analysis

Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the…
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million

As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion

By Dylan Haversack on December 14, 2020
Posted in Trends & Analysis

AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion…
Continue Reading As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion

Hyundai Buys Majority of Boston Dynamics from SoftBank in $1.1B deal

By Dan Shores on December 14, 2020
Posted in Trends & Analysis

Hyundai is reportedly in the process of purchasing a large controlling interest in robot innovator Boston Dynamics from SoftBank in

…
Continue Reading Hyundai Buys Majority of Boston Dynamics from SoftBank in $1.1B deal

Pixelated trademark

Practice Tips: Fair Use of a Trademark (Part I)

By Davide F. Schiavetti on December 9, 2020
Posted in Featured, Guidance

One of the first things entrepreneurs will need to do when branding new companies is to seek and obtain trademark…
Continue Reading Practice Tips: Fair Use of a Trademark (Part I)

Writer at work

Tips for Reviewing (or Drafting) Patent Claims

By Eric D. Blatt on December 7, 2020
Posted in Featured, Guidance

For emerging companies, a patent application should combine legal skill with technical and business knowledge to produce a document that…
Continue Reading Tips for Reviewing (or Drafting) Patent Claims

Post navigation

Older Posts 
Rothwell, Figg, Ernst & Manbeck, P.C.
Subscribe to this Blog
Washington, DC
607 14th St. NW
Suite 800
Washington, DC 20005
202.783.6040
info@rfem.com
Boston
One Boston Place
Suite 2600
Boston, MA 02108
617.312.3101
info@rfem.com
RSS LinkedIn Twitter Facebook
Privacy PolicyDisclaimer

About Our Firm

To learn more about our firm and other practice areas, visit: www.rfem.com.

Rothwell Figg Blogs

  • Biosimilars Law Bulletin
  • Privacy Zone
  • PTAB Law Blog
Copyright © 2021, Rothwell, Figg, Ernst & Manbeck, P.C. All Rights Reserved.
Powered By LexBlog

We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.

Agree